Inventor · Pearland, TX, US

Jason CROSS

36Patents
4h-index
40Co-inventors
59Inventor score

Filing activity: Mar 29, 2013 → Jul 20, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US10280171B2 Heterocyclic inhibitors of PTPN11 Chemistry; Metallurgy 24 Active
US10421765B2 Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase Chemistry; Metallurgy 6 Active
US10392376B2 Heterocyclic inhibitors of ATR kinase Human Necessities 6 Active
US11104675B2 PTPN11 inhibitors Chemistry; Metallurgy 5 Active
US10851110B2 Heterocyclic inhibitors of PTPN11 Chemistry; Metallurgy 4 Active
US10954243B2 Substituted heterocyclic inhibitors of PTPN11 Chemistry; Metallurgy 4 Active
US10745420B2 Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase Chemistry; Metallurgy 2 Active
US11690850B2 Inhibitors of receptor interacting protein kinase I for the treatment of disease Chemistry; Metallurgy 2 Active
US10800769B2 Heterocyclic inhibitors of ATR kinase Human Necessities 2 Active
US10093664B2 Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease Chemistry; Metallurgy 2 Active
US10800774B2 Heterocyclic inhibitors of ATR kinase Chemistry; Metallurgy 2 Active
US11058688B2 Imidazopiperazine inhibitors of transcription activating proteins Chemistry; Metallurgy 1 Active
US10899769B2 Imidazopiperazinone inhibitors of transcription activating proteins Chemistry; Metallurgy 1 Active
US10428057B2 Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease Chemistry; Metallurgy 1 Active
US8916709B2 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors Emerging Cross-Sectional Technologies 1 Active
US11753381B2 Inhibitors of receptor interacting protein kinase I for the treatment of disease Chemistry; Metallurgy 1 Active
US11718612B2 Inhibitors of receptor interacting protein kinase I for the treatment of disease Chemistry; Metallurgy 1 Active
US8927724B2 Isoxazole beta-lactamase inhibitors Emerging Cross-Sectional Technologies 0 Active
US12286406B2 Inhibitors of receptor interacting protein kinase I for the treatment of disease Chemistry; Metallurgy 0 Active
US8933233B2 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors Emerging Cross-Sectional Technologies 0 Active
US11840536B2 Heterocyclic inhibitors of PTPN11 Chemistry; Metallurgy 0 Active
US11932643B2 Substituted heterocyclic inhibitors of PTPN11 Chemistry; Metallurgy 0 Active
US8940897B2 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors Emerging Cross-Sectional Technologies 0 Active
US8962844B2 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors Emerging Cross-Sectional Technologies 0 Active
US8933232B2 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.